Results 281 to 290 of about 1,772,484 (313)

Discovery of Nanosota-EB1 and -EB2 as Novel Nanobody Inhibitors Against Ebola Virus Infection. [PDF]

PLoS Pathog
Bu F, Ye G, Morsheimer K, Mendoza A, Turner-Hubbard H, Herbst M, Spiller B, Wadzinski BE, Eaton B, Anantpadma M, Yang G, Liu B, Davey R, Li F.   +13 more
europepmc   +1 more source

Covalent Modifications of the Ebola Virus Glycoprotein

, 2002
Scott A. Jeffers, David Avram Sanders, Anthony Sanchez   +2 more
openalex   +1 more source

Molecular basis for the increased fusion activity of the Ebola virus glycoprotein epidemic variant A82V: Insights from simulations and experiments. [PDF]

Cell Rep
Durham ND, Jain A, Howard A, Luban J, Munro JB.   +4 more
europepmc   +1 more source

A public, cross-reactive glycoprotein epitope confounds Ebola virus serology. [PDF]

J Med Virol
Kainulainen MH, Harmon JR, Karaaslan E, Kyondo J, Whitesell A, Twongyeirwe S, Malenfant JH, Baluku J, Kofman A, Bergeron É, Waltenburg MA, Nyakarahuka L, Balinandi S, Cossaboom CM, Choi MJ, Shoemaker TR, Montgomery JM, Spiropoulou CF.   +17 more
europepmc   +1 more source

Surviving Ebola virus [PDF]

The Lancet Infectious Diseases, 2019
openaire   +2 more sources

Perceived drivers of the Ebola virus disease outbreak in Mubende and Kassanda districts, Uganda: a qualitative study. [PDF]

BMJ Public Health
Ninsiima LR, Mor SM, Romano JS, Namakula LN, Kankya C, Kungu J, Mugisha L, Klein J, Nyakarahuka L.   +8 more
europepmc   +1 more source

Corneal and conjunctival abnormalities in a cohort of survivors from the Western African Ebola virus disease outbreak. [PDF]

AJO Int
Fashina T, Nguyen NV, Huang Y, Randleman C, Hartley CD, Mattia JG, Vandy MJ, Harrison-Williams LC, Mustapha J, Mwanza JC, Hayek BR, Crozier I, Shantha JG, Yeh S.   +13 more
europepmc   +1 more source

Neonatal Survival Following Spontaneous Maternal Recovery From Ebola Virus Disease in a Resource-Limited Setting in Western Democratic Republic of the Congo. [PDF]

Case Rep Infect Dis
Imani-Musimwa P, Grant E, Mukadi-Bamuleka D, Fraterne-Muhayangabo R, Kitenge-Omasumbu R, Mbala-Kingebeni P, Tsongo-Kibendelwa Z, Nyakio-Ngeleza O, Claris-Mwatsi I, Sihali-Kyolov J, Barhwamire-Kabesha T, Kavira-Malengera C, Feza-Malira M, Bitwe-Mihanda R, Sengeyi-Mushengezi-Amani D, Ververs M.   +15 more
europepmc   +1 more source

A conformable mathematical model of Ebola Virus Disease and its stability analysis. [PDF]

Heliyon
Abbas N, Zanib SA, Ramzan S, Nazir A, Shatanawi W.   +4 more
europepmc   +1 more source

Long-term cellular immunity of vaccines for Zaire Ebola Virus Diseases. [PDF]

Nat Commun
Wiedemann A, Lhomme E, Huchon M, Foucat E, Bérerd-Camara M, Guillaumat L, Yaradouno M, Tambalou J, Rodrigues C, Ribeiro A, Béavogui AH, Lacabaratz C, Thiébaut R, Richert L, Lévy Y, Prevac study team.   +15 more
europepmc   +1 more source